HLA-Haploidentical Bone Marrow Transplantation for Hematologic Malignancies Using Nonmyeloablative Conditioning and High-Dose, Posttransplantation CyclophosphamideLeo Luznik, Ephraim J. Fuchs, Paul V. O’Donnell et al.|Biology of Blood and Marrow Transplantation|2008Cited by 1.9k
Hematopoietic cell transplantation in older patients with hematologic malignancies: replacing high-dose cytotoxic therapy with graft-versus-tumor effectsPeter A. McSweeney, Rainer Storb, Dietger Niederwieser et al.|Blood|2001Cited by 1.4k
Allografting with nonmyeloablative conditioning following cytoreductive autografts for the treatment of patients with multiple myelomaDavid G. Maloney, Rainer Storb, Arthur J. Molina et al.|Blood|2003Cited by 407
Long-term Outcomes Among Older Patients Following Nonmyeloablative Conditioning and Allogeneic Hematopoietic Cell Transplantation for Advanced Hematologic MalignanciesMohamed L. Sorror, Rainer Storb, Michael A. Pulsipher et al.|JAMA|2011Cited by 320
Comparison of Outcomes of HLA-Matched Related, Unrelated, or HLA-Haploidentical Related Hematopoietic Cell Transplantation following Nonmyeloablative Conditioning for Relapsed or Refractory Hodgkin LymphomaLauri M. Burroughs, David G. Maloney, Paul V. O’Donnell et al.|Biology of Blood and Marrow Transplantation|2008Cited by 264